These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 4996213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Myelodepressive effect during intracavitary cytostatic treatment of bladder tumors].
    González R, Millones A, Guzmán A, Gelabert A.
    Arch Esp Urol; 1979; 32(1):49-52. PubMed ID: 109052
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of chemotherapeutic agents in the prophylaxis of papillary bladder tumours.
    Pavone-Macaluso M, Caramia G, Rizzo FP.
    Urol Int; 1971; 26(5):379-87. PubMed ID: 5136749
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Thio-Tepa in the chemotherapy and chemical prevention of papillary neoplasms of the bladder].
    Delzotto L, Viggiano G, Marchini M, Barbui PE.
    Minerva Med; 1977 Jun 02; 68(28):1957-60. PubMed ID: 406584
    [No Abstract] [Full Text] [Related]

  • 12. [Intraluminal visceral chemotherapy of noninfiltrating cancers of the bladder (preliminary report)].
    Mocellini Iturralde JA, Rapaport M, Montenegro L, Arrighi A.
    Rev Argent Urol Nefrol; 1970 Jun 02; 39(7):144-51. PubMed ID: 4999227
    [No Abstract] [Full Text] [Related]

  • 13. Early onset life-threatening myelosuppression after low dose of intravesical thiotepa.
    Agnelli G, de Cunto M, Gresele P, del Favero A.
    Postgrad Med J; 1982 Jun 02; 58(680):380-1. PubMed ID: 6812036
    [Abstract] [Full Text] [Related]

  • 14. [Cytostatic prophylactic treatment of superficial bladder tumours].
    Lunglmayr G.
    Urologe A; 1972 Mar 02; 11(2):94-7. PubMed ID: 4623214
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.
    Friedell GH.
    Cancer Chemother Pharmacol; 1983 Mar 02; 11 Suppl():S13-5. PubMed ID: 6416697
    [Abstract] [Full Text] [Related]

  • 17. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
    Rampal M, Alimi JC, Pons G, Fiquet JM.
    J Urol Nephrol (Paris); 1978 Mar 02; 84(3):271-4. PubMed ID: 417193
    [No Abstract] [Full Text] [Related]

  • 18. Chemotherapy of bladder tumours.
    Pavone-Macaluso M.
    Urol Res; 1978 Mar 02; 6(4):259-62. PubMed ID: 105444
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravesical thiotepa in the treatment of transitional cell bladder carcinoma.
    Mitchell RJ.
    Br J Urol; 1971 Apr 02; 43(2):185-8. PubMed ID: 4996214
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.